THE INFLUENCE OF MARKERS IN THE DIFFERENTIATION PROCESS OF STEM CELLS INTO ENDOTHELIAL CELLS TO SUPPORT TREATMENT TESTING EXPERIMENTS
THE INFLUENCE OF MARKERS IN THE DIFFERENTIATION PROCESS OF STEM CELLS INTO ENDOTHELIAL CELLS TO SUPPORT TREATMENT TESTING EXPERIMENTS
Downloads
Research on stem cells, particularly their differentiation into endothelial cells, is highly significant in the field of biomedical science and regenerative therapy. Endothelial cells are crucial for blood vessel formation, wound healing, tissue regeneration, and the treatment of degenerative diseases. Human pluripotent stem cells can differentiate into various cell types, making them valuable for repairing or replacing damaged tissue. This study reviews the role of markers in distinguishing human stem cells into endothelial cells. A comprehensive literature search was conducted, and out of 428 screened articles, only 4 met the inclusion criteria. SOXF proteins were analyzed using scRNA-seq analysis, focusing on their role in enhancing stem cell differentiation. SOX17 was found to significantly increase the percentage of cells expressing CD34+ and Vascular Endothelial Cadherin (VEC), consistent with its known role in endoderm differentiation and endothelial cell specification. SOX17 can override pluripotency signals in human stem cells, triggering their differentiation into endothelial cells. Overexpression of SOX17 in human stem cells resulted in cells with endothelial characteristics, and combining SOX17 with FGF2 enhanced this effect, resulting in more than 90% of cells expressing endothelial stem cell markers (CD34+, VEC+, CD31+). SOXF was applied to prompt stem cell differentiation, with only SOX17 demonstrating notable effectiveness.
Aprile, D., Patrone, D., Peluso, G. and Galderisi, U. (2024), "Multipotent/pluripotent stem cell populations in stromal tissues and peripheral blood: exploring diversity, potential, and therapeutic applications”, Stem Cell Research & Therapy, Vol. 15 No. 1, pp. 139.
Baumheter, S., Singer, M. S., Henzel, W., Hemmerich, S., Renz, M., Rosen, S. D. and Lasky, L. A. (1993), "Binding of Lselectin to the vascular sialomucin CD34”, Science, Vol. 262 No. 5132, pp. 436-8.
Ellistasari, E. Y., Kariosentono, H., Purwanto, B., Wasita, B., Riswiyant, R. C. A., Pamungkasari, E. P. and Soetrisno, S. (2022), "Role of Exosomes Derived from Secretome Human Umbilical Vein Endothelial Cells (Exo-HUVEC) as AntiApoptotic, Anti-Oxidant, and Increasing Fibroblast Migration in Photoaging Skin Models”, Clinical, cosmetic and investigational dermatology, Vol. 15, pp. 1583-91.
Huang, Y., Hamana, T., Liu, J., Wang, C., An, L., You, P., Chang, J. Y. F., Xu, J., Jin, C., Zhang, Z., McKeehan, W. L. and Wang, F. (2015), "Type 2 Fibroblast Growth Factor Receptor Signaling Preserves Stemness and Prevents Differentiation of Prostate Stem Cells from the Basal Compartment”, The Journal of biological chemistry, Vol. 290 No. 29, pp. 17753-61.Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H. and Benvenisty, N. (2000), "Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers”, Molecular medicine, Vol. 6 No. 2, pp. 88-95.
Irie, N., Kobayashi, T. and Surani, M. A. (2024), "Human Primordial Germ Cell-Like Cell Induction from Pluripotent Stem Cells by SOX17 and PRDM1 Expression”, Methods in molecular biology, Vol. 2770, pp. 87-97.
Kennedy, C. C., Brown, E. E., Abutaleb, N. O. and Truskey, G. A. (2021), "Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models”, Frontiers in cardiovascular medicine, Vol. 8, pp. 1-6.
Mimura, S., Suga, M., Liu, Y., Kinehara, M., Yanagihara, K., Ohnuma, K., Nikawa, H. and Furue, M. K. (2015), "Synergistic effects of FGF-2 and Activin A on early neural differentiation of human pluripotent stem cells”, In vitro cellular & developmental biology, Vol. 51 No. 8, pp. 769-75.
Mossahebi-Mohammadi, M., Quan, M., Zhang, J-S. and Li, X. (2020), "FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency”, Frontiers in cell and developmental biology, Vol. 8, pp. 79.
Nielsen, J. S. and McNagny, K. M. (2008), "Novel functions of the CD34 family”, Journal of cell science, Vol. 121 No. 22, pp. 3683-92.
Paik, D. T., Tian, L., Lee, J., Sayed, N., Chen, I. Y., Rhee, S., Rhee, J-W., Kim, Y., Wirka, R. C., Buikema, J. W., Wu, S. M., Red-Horse, K., Quertermous, T. and Wu, J. C. (2018), "Large-Scale Single-Cell RNA-Seq Reveals Molecular Signatures of Heterogeneous Populations of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells”, Circulation research, Vol. 123 No. 4, pp. 443-50.
Pettinato, G., Vanden Berg-Foels, W. S., Zhang, N. and Wen, X. (2014), "ROCK Inhibitor Is Not Required for Embryoid Body Formation from Singularized Human Embryonic Stem Cells”, PLoS One, Vol. 9 No. 11, p. e100742.
Radu, P., Zurzu, M., Paic, V., Bratucu, M., Garofil, D., Tigora, A., Gerogescu, V., Prunoiu, V., Pasnicu, C., Popa, F., Surlin, P., Surlin, V. and Strambu, V. (2023), "CD34”Structure, Functions and Relationship with Cancer Stem Cells”, Medicina, Vol. 59 No. 5, pp. 938.
Ream, M. W., Randolph, L. N., Jiang, Y., Chang, Y., Bao, X. and Lian, X. L. (2024), "Direct programming of human pluripotent stem cells into endothelial progenitors with SOX17 and FGF2”, Stem cell reports, Vol. 19 No. 4, pp. 579-95.
Sidney, L. E., Branch, M. J., Dunphy, S. E., Dua, H. S. and Hopkinson, A. (2014), "Concise review: evidence for CD34 as a common marker for diverse progenitors”, Stem cells, Vol. 32 No. 6, pp. 1380-9.
Tchieu, J., Calder, E. L., Guttikonda, S. R., Gutzwiller, E. M., Aromolaran, K. A., Steinbeck, J. A., Goldstein, P. A., Studer, L. (2019), "NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells”, Nature biotechnology, Vol. 37 No. 3, pp. 267-75.
Tian, R., Yao, C., Yang, C., Zhu, Z., Li, C., Zhi, E., Wang, J., Li, P., Chen, H., Yuan, Q., He, Z. and Li, Z. (2019), "Fibroblast growth factor-5 promotes spermatogonial stem cell proliferation via ERK and AKT activation”, Stem Cell Research & Therapy, Vol. 10 No. 1, pp. 1-4.
Trinh, L. T., Osipovich, A. B., Liu, B., Shrestha, S., Cartailler, J-P., Wright, C. V. E. and Magnuson, M. A. (2023), "Single-Cell RNA Sequencing of Sox17-Expressing Lineages Reveals Distinct Gene Regulatory Networks and Dynamic Developmental Trajectories”, Stem cells, Vol. 41 No. 6, pp. 643-57.
Veres, A., Faust, A. L., Bushnell, H. L., Engquist, E. N., Kenty, J. H-R., Harb, G., Poh, Y-C., Sintov, E., Gürtler, M., Pagliuca, F. W., Peterson, Q. P. and Melton, D. A. (2019), "Charting cellular identity during human in vitro β-cell differentiation”, Nature, Vol. 569 No. 7756, pp. 368-73.
Wang, K., Lin, R-Z., Hong, X., Ng, A. H., Lee, C. N., Neumeyer, J., Wang, G., Wang, X., Ma, M., Pu, W. T., Church, G. M. and Melero-Martin, J. M. (2020), "Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified Mrna”, Science advances, Vol. 6 No. 30, pp. 1-5.
Zakrzewski, W., DobrzyÅ„ski, M., Szymonowicz, M. and Rybak, Z. (2019), "Stem cells: past, present, and future”, Stem Cell Research & Therapy, Vol. 10 No. 1, pp. 68.
Copyright (c) 2024 Journal of Stem Cell Research and Tissue Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. As an author you (or your employer or institution) may do the following:
- make copies (print or electronic) of the article for your own personal use, including for your own classroom teaching use;
- make copies and distribute such copies (including through e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g. via an e-mail list or list server);
- present the article at a meeting or conference and to distribute copies of the article to the delegates attending such meeting;
- for your employer, if the article is a ‘work for hire', made within the scope of your employment, your employer may use all or part of the information in the article for other intra-company use (e.g. training);
- retain patent and trademark rights and rights to any process, procedure, or article of manufacture described in the article;
- include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
- use the article or any part thereof in a printed compilation of your works, such as collected writings or lecture notes (subsequent to publication of the article in the journal); and prepare other derivative works, to extend the article into book-length form, or to otherwise re-use portions or excerpts in other works, with full acknowledgement of its original publication in the journal;
- may reproduce or authorize others to reproduce the article, material extracted from the article, or derivative works for the author's personal use or for company use, provided that the source and the copyright notice are indicated, the copies are not used in any way that implies JSCRTE endorsement of a product or service of any employer, and the copies themselves are not offered for sale.
All copies, print or electronic, or other use of the paper or article must include the appropriate bibliographic citation for the article's publication in the journal.
2. Requests from third parties
Although authors are permitted to re-use all or portions of the article in other works, this does not include granting third-party requests for reprinting, republishing, or other types of re-use. Requests for all uses not included above, including the authorization of third parties to reproduce or otherwise use all or part of the article (including figures and tables), should be referred to JSCRTE by going to our website at http://e-journal.unair.ac.id/index.php/JSCRTE
3. Author Online Use
- Personal Servers. Authors and/or their employers shall have the right to post the accepted version of articles pre-print version of the article, or revised personal version of the final text of the article (to reflect changes made in the peer review and editing process) on their own personal servers or the servers of their institutions or employers without permission from JSCRTE, provided that the posted version includes a prominently displayed JSCRTE copyright notice and, when published, a full citation to the original publication, including a link to the article abstract in the journal homepage. Authors shall not post the final, published versions of their papers;
- Classroom or Internal Training Use. An author is expressly permitted to post any portion of the accepted version of his/her own articles on the author's personal web site or the servers of the author's institution or company in connection with the author's teaching, training, or work responsibilities, provided that the appropriate copyright, credit, and reuse notices appear prominently with the posted material. Examples of permitted uses are lecture materials, course packs, e-reserves, conference presentations, or in-house training courses;
- Electronic Preprints. Before submitting an article to an JSCRTE, authors frequently post their manuscripts to their own web site, their employer's site, or to another server that invites constructive comment from colleagues. Upon submission of an article to JSCRTE, an author is required to transfer copyright in the article to JSCRTE, and the author must update any previously posted version of the article with a prominently displayed JSCRTE copyright notice. Upon publication of an article by the JSCRTE, the author must replace any previously posted electronic versions of the article with either (1) the full citation to the work with a Digital Object Identifier (DOI) or link to the article abstract in JSCRTE homepage, or (2) the accepted version only (not the final, published version), including the JSCRTE copyright notice and full citation, with a link to the final, published article in journal homepage.
4. Articles in Press (AiP) service
JSCRTE may choose to publish an abstract or portions of the paper before we publish it in the journal. Please contact our Production department immediately if you do not want us to make any such prior publication for any reason, including disclosure of a patentable invention.
5. Author/Employer Rights
If you are employed and prepared the article on a subject within the scope of your employment, the copyright in the article belongs to your employer as a work-for-hire. In that case, JSCRTE assumes that when you sign this Form, you are authorized to do so by your employer and that your employer has consented to the transfer of copyright, to the representation and warranty of publication rights, and to all other terms and conditions of this Form. If such authorization and consent has not been given to you, an authorized representative of your employer should sign this Form as the Author.
6. JSCRTE Copyright Ownership
It is the formal policy of JSCRTE to own the copyrights to all copyrightable material in its technical publications and to the individual contributions contained therein, in order to protect the interests of the JSCRTE, its authors and their employers, and, at the same time, to facilitate the appropriate re-use of this material by others. JSCRTE distributes its technical publications throughout the world and does so by various means such as hard copy, microfiche, microfilm, and electronic media. It also abstracts and may translate its publications, and articles contained therein, for inclusion in various compendiums, collective works, databases and similar publications
Every accepted manuscript should be accompanied by "Copyright Transfer Agreement" prior to the article publication.
